3D Bioprinting Market: Information by Technology (Magnetic Levitation) Application (Medical, Dental, Biosensors, Food, and Animal  Products), and Region — Forecast till 2029

Aug 26, 2020   Market Overview Three-dimensional (3D) bioprinting is used to combine cells, growth factors, and biomaterials to manufacture biomedical parts that mimic the natural properties of the tissue. 3D Bioprinting is a process where bioink — consisting of living cells — and biomaterials and structural scaffolds are deposited on the surface to produce 3D structures. The 3D bioprinting market was valued at USD 970.5 million in 2019 and is expected to grow with a CAGR of 18.7% during the fore...
Request Free Sample Report

Table Of Content

TABLE OF CONTENTS

1          Introduction

1.1       Market Definition

1.2       Market Scope

2          Research Methodology

2.1       Primary Research

2.2       Research Methodology

2.3       Assumptions & Exclusions

2.4       Secondary Data Applications

3          Market Overview

3.1       Report Segmentation & Scope

3.2       Value Chain Analysis:  3D Bioprinting Market

3.3       Key Market Trends

3.3.1   Drivers

3.3.2   The Restraints

3.3.3   Opportunities

3.4       Porter’s Five Forces Analysis

3.4.1   Bargaining Power of Suppliers

3.4.2   Bargaining Power of Buyers

3.4.3   Threat of Substitution

3.4.4   Threat of New Entrants

3.4.5   Competitive Rivalry

3.5       Market Share Analysis

3.6       Top Wining Strategies

3.7       Top Investment Pockets

3.8       Impact of COVID 19

4          Technology Overview

4.1       Introduction

4.1.1   Market Size & Forecast (Value)

4.2       Magnetic Levitation

4.2.1   Market Size & Forecast (Value)

4.3       Inkjet-Based

4.3.1   Market Size & Forecast (Value)

4.4       Syringe-Based

4.4.1   Market Size & Forecast (Value)

4.5       Laser-Based

4.5.1   Market Size & Forecast (Value)

4.6       Other

4.6.1   Market Size & Forecast (Value)

5          Applications Overview

5.1       Introduction

5.1.1   Market Size & Forecast (Value)

5.2       Medical

5.2.1   Market Size & Forecast (Value)

5.2.2     Tissue and Organ Generation

5.2.2.1            Market Size & Forecast (Value)

5.2.3     Medical Pills

5.2.3.1            Market Size & Forecast (Value)

5.2.4     Prosthetics and Implant

5.2.4.1            Market Size & Forecast (Value)

5.3       Dental

5.3.1   Market Size & Forecast (Value)

5.4       BIOSENSOR

5.4.1   Market Size & Forecast (Value)

5.5       Consumer /Personal Product Testing

5.5.1   Market Size & Forecast (Value)

5.6       Bioink

5.6.1   Market Size & Forecast (Value)

5.7       Food and Animal Products

5.7.1   Market Size & Forecast (Value)

6          Regional Overview

6.1      Introduction

6.1.1   Market Size & Forecast (Value)

6.2      North America

6.2.1   North America

6.2.1.1      The U.S.

6.2.1.1.1         By Technology

6.2.1.1.2         By Applications

6.2.1.2      Canada

6.2.1.2.1         By Technology

6.2.1.2.2         By Applications

6.2.1.3      Mexico

6.2.1.3.1         By Technology

6.2.1.3.2         By Applications

6.2.2   Central and South America and Caribbean

6.2.2.1      By Technology

6.2.2.2      By Applications

6.2.2.2.1   Brazil

6.2.2.2.1.1      By Technology

6.2.2.2.1.2      By Applications

6.2.2.2.2   Argentina

6.2.2.2.2.1      By Technology

6.2.2.2.2.2      By Applications

6.2.2.2.3   The Rest of Central and South America and Caribbean

6.2.2.2.3.1      By Technology

6.2.2.2.3.2      By Applications

6.3      Europe

6.3.1   Market Size & Forecast (Value)

6.3.2   Western Europe

6.3.2.1      The U.K.

6.3.2.1.1         By Technology

6.3.2.1.2         By Applications

6.3.2.2      Germany

6.3.2.2.1         By Technology

6.3.2.2.2         By Applications

6.3.2.3      France

6.3.2.3.1         By Technology

6.3.2.3.2         By Applications

6.3.2.4      Spain

6.3.2.4.1         By Technology

6.3.2.4.2         By Applications

6.3.2.5      Italy

6.3.2.5.1         By Technology

6.3.2.5.2         By Applications

6.3.2.6      The Rest of Western Europe

6.3.2.6.1         By Technology

6.3.2.6.2         By Applications

6.3.3   Eastern Europe

6.3.3.1  By Technology

6.3.3.2  By Applications

6.3.4   The Rest of Europe

6.3.4.1  By Technology

6.3.4.2  By Applications

6.4      Asia-Pacific

6.4.1   Market Size & Forecast (Value)

6.4.2   Japan

6.4.2.1            By Technology

6.4.2.2            By Applications

6.4.3   China

6.4.3.1            By Technology

6.4.3.2            By Applications

6.4.4   Australia

6.4.4.1            By Technology

6.4.4.2            By Applications

6.4.5   India

6.4.5.1            By Technology

6.4.5.2            By Applications

6.4.6   South Korea

6.4.6.1            By Technology

6.4.6.2            By Applications

6.4.7   The Rest of Asia-Pacific

6.4.7.1            By Technology

6.4.7.2            By Applications

6.5      The Middle East & Africa

6.5.1   The Middle East

6.5.1.1            Market Size & Forecast (Value)

6.5.1.2            Saudi Arabia

6.5.1.2.1         By Technology

6.5.1.2.2         By Applications

6.5.1.3            The UAE

6.5.1.3.1         By Technology

6.5.1.3.2         By Applications

6.5.1.4            Qatar

6.5.1.4.1         By Technology

6.5.1.4.2         By Applications

6.5.2   The Africa

6.5.2.1            Market Size & Forecast (Value) 

7          Company Profile

7.1      Organovo Holding, Inc.

7.1.1   Company Overview

7.1.2   Financial Performance

7.1.3   Recent Developments

7.1.4   Technology Portfolio

7.2      Luxexcel Group B.V.

7.2.1   Company Overview

7.2.2   Financial Performance

7.2.3   Recent Developments

7.2.4   Technology Portfolio

7.3      TeVido BioDevices

7.3.1   Company Overview

7.3.2   Financial Performance

7.3.3   Recent Developments

7.3.4   Technology Portfolio

7.4      3Dynamics Systems Ltd.

7.4.1   Company Overview

7.4.2   Financial Performance

7.4.3   Recent Developments

7.4.4   Technology Portfolio

7.5      Cyfuse Biomedical K.K

7.5.1   Company Overview

7.5.2   Financial Performance

7.5.3   Recent Developments

7.5.4   Technology Portfolio

7.6      Aspect Biosystems Ltd.

7.6.1   Company Overview

7.6.2   Financial Performance

7.6.3   Recent Developments

7.6.4   Technology Portfolio

7.7      Stratasys Ltd.

7.7.1   Company Overview

7.7.2   Financial Performance

7.7.3   Recent Developments

7.7.4   Technology Portfolio

7.8      Voxeljet A.G.

7.8.1   Company Overview

7.8.2   Financial Performance

7.8.3   Recent Developments

7.8.4   Technology Portfolio

7.9      Heska Corp. Bio3D Technologies Pvt. Ltd

7.9.1   Company Overview

7.9.2   Financial Performance

7.9.3   Recent Developments

7.9.4   Technology Portfolio

8               Conclusion & Recommendations

9               Acronyms & Abbreviations